Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Transplant Hepatology
How do you decide which patient and with which device to pursue machine perfusion for the organ of a liver transplant recipient?
Related Questions
How do you approach the evaluation of a living donor liver transplant candidate?
How do you approach risk of development of PTLD in liver transplant recipients with positive EBV antibodies and/or viral loads?
For how long would you treat a patient with latent TB before allowing them to proceed with a liver transplant?
How much do you factor in a patient's frailty in selection for transplant if the underlying driver for their debility is their underlying liver disease itself?
With an increase in the prevalence of MASLD in the United States population, what recipient and donor characteristics do you find favorable for acceptance of a highly steatotic graft?
Should a patient who requires definitive treatment for prostate cancer as a pre-transplant requirement be strictly required to complete their course prior to transplant/initiation of immunosuppression?
How does the presence of porto-mesenteric vein thrombosis impact a patient's transplant candidacy?
What patient features would favor the creation of a Hutson loop intra-operatively?
What would be the right patient profile and experience for someone who may have (operational) tolerance and how do you approach immunosuppresison management (or withdrawal) in this patient?
What is your strategy to manage the complication of long-term immunosuppression in liver transplant recipients, specifically renal dysfunction and onset of cardiometabolic comorbidities?
